The Reducing Hereditary Cancer Act - This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
He is supporting legislation to expand Medicare coverage for germline mutation testing, risk-reducing surgeries, and cancer screenings for people with hereditary cancer risk.
Occurrences
Evidence
The official Healthcare feed’s newest visible items are dated February 25, 2026, January 15, 2026, and January 8, 2026; none mention Medicare coverage for hereditary-cancer services, germline testing, or risk-reducing surgery.
The latest visible press releases in the lookback window are dated May 28, 2026 and May 26, 2026, and both concern FEMA/homeland-security matters rather than cancer or Medicare policy.
Assessments
The claim is about an ongoing support action rather than a completed policy outcome, and the available evidence does not verify that Kennedy actually sponsored, co-sponsored, or otherwise materially advanced federal legislation to expand Medicare coverage for hereditary-cancer genetic testing, risk-reducing surgeries, and screenings. The cited official House press-release and healthcare feeds through late May 2026 show no visible action tied to this issue, but that absence is not enough to prove the promise was abandoned or failed. With no direct evidence of concrete legislative support and no evidence of enactment, the fairest judgment is unresolved.